课题基金 / 基金详情

TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE IN CHILDREN (TONIC)

TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE IN CHILDREN (TONIC)
儿童非酒精性脂肪肝的治疗(补品)
批准号:
7717035
负责人:
ARUN J SANYAL
金额:
$1.21万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-12-01 至 2008-11-30

项目摘要

项目成果

ARUN J SANYAL的其他基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项随机、多中心、双掩蔽、安慰剂对照试验的主要目标是评估与安慰剂治疗相比,二甲双胍或维生素E治疗96周是否导致患有NAFLD的非糖尿病儿童血清ALT持续降低。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The principal objective of this randomized, multicenter, double-masked, placebo-controlled trial is to evaluate whether 96 weeks of treatment with either metformin or vitamin E leads to sustained reduction in serum ALT in nondiabetic children with NAFLD compared to treatment with placebo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Predicting outcomes in nonalcoholic steatohepatitis with advanced fibrosis
  • 批准号:
    10446281
  • 项目类别:
  • 资助金额:
    $63.45万
  • 财政年份:
    2022
  • 负责人:
    ARUN J SANYAL
  • 依托单位:
Predicting outcomes in nonalcoholic steatohepatitis with advanced fibrosis
  • 批准号:
    10696227
  • 项目类别:
  • 资助金额:
    $58.05万
  • 财政年份:
    2022
  • 负责人:
    ARUN J SANYAL
  • 依托单位:
A PRECLINICAL MODEL OF ALCOHOLIC HEPATITIS
  • 批准号:
    10213324
  • 项目类别:
  • 资助金额:
    $37.65万
  • 财政年份:
    2018
  • 负责人:
    ARUN J SANYAL
  • 依托单位:
Novel Therapies for Alcoholic Hepatitis with Sepsis and for Relapse Prevention
  • 批准号:
    10428495
  • 项目类别:
  • 资助金额:
    $6.31万
  • 财政年份:
    2018
  • 负责人:
    ARUN J SANYAL
  • 依托单位: